Koninklijke Philips N.V. is a Dutch diversified technology company headquartered in Amsterdam with primary divisions focused in the areas of Healthcare, Consumer Lifestyle and Lighting. It was founded in Eindhoven in 1891 by Gerard Philips and his father Frederik. It is one of the largest electronics companies in the world and employs around 122,000 people across more than 60 countries.Philips is organized into three main divisions: Philips Consumer Lifestyle , Philips Healthcare and Philips Lighting. As of 2012 Philips was the largest manufacturer of lighting in the world measured by applicable revenues. In 2013, the company announced the sale of the bulk of its remaining consumer electronics operations to Japan's Funai Electric Co but in October 2013, the deal to Funai Electric Co was broken off and the consumer electronics operations remain under Philips. Philips said it would seek damages for breach of contract in the $200-million sale.Philips has a primary listing on the Euronext Amsterdam stock exchange and is a constituent of the AEX index. It has a secondary listing on the New York Stock Exchange. Wikipedia.
Agency: Cordis | Branch: H2020 | Program: ECSEL-RIA | Phase: ECSEL-04-2015 | Award Amount: 18.33M | Year: 2016
The ageing population and related increase in chronic diseases put considerable pressure on both the healthcare system and the society, resulting in an unsustainable rise of healthcare costs. As a result there is an urgent need to improve efficiency of care and reduce hospitalisation time in order to control cost and increase quality of life. Addressing this need, medical applications need to become less invasive and improve disease detection, diagnosis and treatment using advanced imaging and sensing techniques. ASTONISH will deliver breakthrough imaging and sensing technologies for monitoring, diagnosis and treatment applications by developing smart optical imaging technology that extends the use of minimally invasive diagnosis and treatment and allows for unobtrusive health monitoring. The project will integrate miniaturized optical components, data processing units and SW applications into smart imaging systems that are less obtrusive, cheaper, more reliable and easier to use than state of the art systems. This results into 6 demonstrators by which the technologies will be validated and which allow for pre-clinical testing in the scope of the project. The overall concept within ASTONISH builds on the development and application of common imaging/sensing technologies. Smart algorithms, multimodal fusion techniques and biomedical signal processing will process the acquired data and advanced user interfaces will simplify the complex clinical tasks. These technology components will be integrated to build application specific solutions for physiological signs monitoring, tumour detection, minimally invasive surgery, brain function monitoring and rehabilitation. The ASTONISH partners cover the full value chain, from semiconductor manufacturing to clinical centres testing the final application. The proposed innovations improve the global competitiveness of the European industry in the healthcare domain.
Agency: Cordis | Branch: H2020 | Program: ECSEL-IA | Phase: ECSEL-17-2015 | Award Amount: 64.82M | Year: 2016
ENABLE-S3 will pave the way for accelerated application of highly automated and autonomous systems in the mobility domains automotive, aerospace, rail and maritime as well as in the health care domain. Virtual testing, verification and coverage-oriented test selection methods will enable validation with reasonable efforts. The resulting validation framework will ensure Europeans Industry competitiveness in the global race of automated systems with an expected market potential of 60B in 2025. Project results will be used to propose standardized validation procedures for highly automated systems (ACPS). The technical objectives addressed are: 1. Provision of a test and validation framework that proves the functionality, safety and security of ACPS with at least 50% less test effort than required in classical testing. 2. Promotion of a new technique for testing of automated systems with physical sensor signal stimuli generators, which will be demonstrated for at least 3 physical stimuli generators. 3. Raising significantly the level of dependability of automated systems due to provision of a holistic test and validation platform and systematic coverage measures, which will reduce the probability of malfunction behavior of automated systems to 10E-9/h. 4. Provision of a validation environment for rapid re-qualification, which will allow reuse of validation scenarios in at least 3 development stages. 5. Establish open standards to speed up the adoption of the new validation tools and methods for ACPS. 6. Enabling safe, secure and functional ACPS across domains. 7. Creation of an eco-system for the validation and verification of automated systems in the European industry. ENABLE-S3 is strongly industry-driven. Realistic and relevant industrial use-cases from smart mobility and smart health will define the requirements to be addressed and assess the benefits of the technological progress.
Agency: Cordis | Branch: H2020 | Program: MSCA-ITN-EID | Phase: MSCA-ITN-2016 | Award Amount: 1.53M | Year: 2017
Cardiovascular (CV) disease is a main cause of death worldwide. During adulthood, ischemic heart disease leads to heart failure and perinatally, congenital heart defects are found in over 20% of deaths. Moreover, genetic or epigenetic factors altering development can have an impact much later in life. These facts underscore the need of a better understanding of the genetic and environmental factors that influence CV development. An important way to increase our knowledge is by visualizing cardiac development in vivo. Recent advance in microscopy allows monitoring CV development at a cellular level in organisms such as the zebrafish model. Particularly revolutionary has been the development of light sheet microscopy (LSM). We want to further exploit LSM for in vivo manipulation of cells in the embryonic zebrafish heart and measure with high precision biophysical parameters, by introducing novel features to LSM such as optical tweezers. High throughput cardiac imaging protocols for zebrafish larvae suitable for screenings will be set up. We will develop softwares to enhance resolution of acquisition, large dataset handling and image-processing. The aim is to generate a toolbox to be implemented into existing software packages allowing a complete modeling of zebrafish cardiac morphogenesis. We will adapt LSM for adult zebrafish hearts to study cardiac regeneration and mouse heart development at cellular resolution. Each Early Stage Researchers (ESRs) will develop their own technology to solve a biological problem at the frontier of knowledge. ESRs will receive multidisciplinary (CV development, physics, biocomputing) as well as intersectorial (academic research, SMEs, large companies) training and will achieve unique skills on Microscopy and Image analysis allowing them to interrogate questions on cardiac development and regeneration. Their profile will be at the interface of a bioengineer and a life science researcher filling a currently existing gap on the market.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: ICT-18-2016 | Award Amount: 2.98M | Year: 2017
More and more data is being generated, and analyzing this data drives knowledge and value creation across society. Unlocking this potential requires sharing of (often personal) data between organizations, but this meets unwillingness from data subjects and data controllers alike. Hence, techniques that protect personal information for data access, processing, and analysis are needed. To address this, the SODA project will enable practical privacy-preserving analytics of information from multiple data assets using multi-party computation (MPC) techniques. For this data does not need to be shared, only made available for encrypted processing. The main technological challenge is to make MPC scale to big data, where we will achieve substantial performance improvements. We embed MPC into a comprehensive privacy approach, demonstrated in an ICT-14.b and a healthcare use case. Our first objective is to enable MPC for big data applications by scaling the performance. We follow a use case-driven approach, combining expertise from the domains of MPC and data analytics. Our second objective is to combine these improvements with a multidisciplinary approach towards privacy. By enabling differential privacy in the MPC setting aggregated results will not leak individual personal data. Legal analysis performed in a feedback loop with technical development will ensure improved compliance with EU data privacy regulation. User studies performed in a feedback loop with our consent control component will make data subjects more confident to have their data processed with our techniques. Our final objective is to validate our approach, by applying our results in a medical demonstrator originating from Philips practice and in a use case arising from the ICT-14.b data experimentation incubators. The techniques will be subjected to public hacking challenges. The technical innovations will be released as open-source improvements to the FRESCO MPC framework.
Agency: Cordis | Branch: H2020 | Program: CSA | Phase: IoT-02-2016 | Award Amount: 3.53M | Year: 2017
CREATE-IoTs aim is to stimulate collaboration between IoT initiatives, foster the take up of IoT in Europe and support the development and growth of IoT ecosystems based on open technologies and platforms. This requires synchronisation and alignment on strategic and operational terms through frequent, multi-directional exchanges between the various activities under the IoT Focus Areas (FAs). It also requires cross fertilisation of the various IoT Large Scale Pilots (LSPs) for technological and validation issues of common interest across the various application domains and use cases. CREATE-IoT will align the activities with the Alliance for Internet of Things Innovation (AIOTI) and will coordinate and support the upcoming LSPs in sustaining the ecosystems developed during those projects through mapping the pilot architecture approaches, address interoperability and standards approaches at technical and semantic levels for object connectivity, protocols, data formats, privacy, security, trusted IoT, open APIs and share the road-mapping with international initiatives. The project will foster the exchange on requirements for legal accompanying measures, development of common methodologies and KPI for design, testing and validation and for success and impact measurement, federation of pilot activities and transfer to other pilot areas, facilitating the access for IoT entrepreneurs/API developers/makers, SMEs, including combination of ICT & Art. CREATE-IoT will build strong connections with Member States initiatives and other initiatives and will transfer learning points to the broader IoT policy framework that include contractual PPPs (e.g. Big Data, Factories of the Future, 5G-infrastructure), Joint Technology Initiatives (e.g. ECSEL), European Innovation Partnerships (e.g. on Smart Cities) as well as other FAs (e.g. on Autonomous transport). It will also maintain a coordinated working relationship with the parallel CSA that is centere on RRI-SSH.
Agency: Cordis | Branch: H2020 | Program: IA | Phase: IoT-01-2016 | Award Amount: 34.71M | Year: 2017
The IoF2020 project is dedicated to accelerate adoption of IoT for securing sufficient, safe and healthy food and to strengthen competitiveness of farming and food chains in Europe. It will consolidate Europes leading position in the global IoT industry by fostering a symbiotic ecosystem of farmers, food industry, technology providers and research institutes. The IoF2020 consortium of 73 partners, led by Wageningen UR and other core partners of previous key projects such as FIWARE and IoT-A, will leverage the ecosystem and architecture that was established in those projects. The heart of the project is formed by 19 use cases grouped in 5 trials with end users from the Arable, Dairy, Fruits, Vegetables and Meat verticals and IoT integrators that will demonstrate the business case of innovative IoT solutions for a large number of application areas. A lean multi-actor approach focusing on user acceptability, stakeholder engagement and sustainable business models will boost technology and market readiness levels and bring end user adoption to the next stage. This development will be enhanced by an open IoT architecture and infrastructure of reusable components based on existing standards and a security and privacy framework. Anticipating vast technological developments and emerging challenges for farming and food, the 4-year project stays agile through dynamic budgeting and adaptive decision-making by an implementation board of representatives from key user organizations. A 6 M mid-term open call will allow for testing intermediate results and extending the project with technical solutions and test sites. A coherent dissemination strategy for use case products and project learnings supported by leading user organizations will ensure a high market visibility and an increased learning curve. Thus IoF2020 will pave the way for data-driven farming, autonomous operations, virtual food chains and personalized nutrition for European citizens.
Agency: Cordis | Branch: H2020 | Program: IA | Phase: IoT-01-2016 | Award Amount: 20.05M | Year: 2017
SynchroniCity represents the first attempt to deliver a Single Digital City Market for Europe by piloting its foundations at scale in 11 reference zones - 8 European cities & 3 more worldwide cities - connecting 34 partners from 11 countries over 4 continents. Building upon a mature European knowledge base derived from initiatives such as OASC, FIWARE, FIRE, EIP-SCC, and including partners with leading roles in standardization bodies, e.g. ITU, ETSI, IEEE, OMA, IETF, SynchroniCity will deliver a harmonized ecosystem for IoT-enabled smart city solutions where IoT device manufacturers, system integrators and solution providers can innovate and openly compete. With an already emerging foundation, SynchroniCity will establish a reference architecture for the envisioned IoT-enabled city market place with identified interoperability points and interfaces and data models for different verticals. This will include tools for co-creation & integration of legacy platforms & IoT devices for urban services and enablers for data discovery, access and licensing lowering the barriers for participation on the market. SynchroniCity will pilot these foundations in the reference zones together with a set of citizen-centred services in three high-impact areas, showing the value to cities, businesses and citizens involved, linked directly to the global market. With a running start, SynchroniCity will serve as lighthouse initiative to inspire others to join the established ecosystem and contribute to the emerging market place. SynchroniCity takes an inclusive approach to grow the ecosystem by inviting businesses and cities to join through an open call, allowing them to participate on the pioneering market place enabling a second wave of successful pilots. They will strengthen the ecosystem by creating a positive ripple effect throughout Europe, and globally, to establish a momentum and critical mass for a strong European presence in a global digital single market of IoT-enabled solutions.
Agency: Cordis | Branch: H2020 | Program: IA | Phase: ICT-02-2016 | Award Amount: 9.08M | Year: 2017
The InSCOPE project will set-up an open access pilot line service for Hybrid TOLAE (H-TOLAE) technologies capable of sampling products at TRL6-7. It positions itself in between R&D and industry and deploys a service for validating potential H-TOLAE products. Manufacturing progresses beyond R&D level (TRL5 towards 6) by improving processes, functionality and reliability allowing sampling at high quality and in relevant numbers needed for industrial qualification (TRL 6-7). The applications addressed cover automotive, healthcare, smart packaging and buildings. After InSCOPE, the Pilot line service will remain accessible to interested parties. The pilot line is serviced by top European RTDs with leading technological positions and state of the art equipment in the domain of H-TOLAE. InSCOPE will set up an open access pilot line infrastructure for H-TOLAE technology, which is modular ensuring a comprehensive toolbox of printing, assembly, production integration and process validation distributed over the partners. InSCOPE will ensure interoperability between the differing modules at the partners enabling end-users to combine different processes step from different partners in their process flow. It will accelerate the uptake of H-TOLAE technology by delivering a public handbook describing functionalities, production guidelines and design rules of H-TOLAE, including new opportunities for traditional electronics. Validation of the pilot line service by 4 Showcases and 15 development cases are included within the project. The Showcases consist of H-TOLAE product prototypes at TRL 5 to be matured on functionality and on manufacturability. The showcases will steer the pilot line improvement. They are selected based on their economic impact as well as the technological status of the product and production in Europe. The development cases are devoted to new functionalities enabled by H-TOLAE. They are aimed at SMEs interested in exploring the broad advantages H-TOLAE.
Agency: Cordis | Branch: H2020 | Program: ECSEL-IA | Phase: ECSEL-15-2015 | Award Amount: 65.27M | Year: 2016
The EU has set the stage to empower semiconductor manufacturing in Europe being one of the key drivers for innovation and employment and creator for answers to the challenges of the modern society. Aim of IoSense is to boost the European competitiveness of ECS industries by increasing the pilot production capacity and improving Time-to-Market for innovative microelectronics, accomplished by establishing three fully connected semiconductor pilot lines in Europe: two 200mm frontend (Dresden and Regensburg) and one backend (Regensburg) lines networking with existing highly specialized manufacturing lines. Focus is the availability of top innovative, competitive sensors and sensor systems Made in Europe for applications in Smart Mobility, Society, Energy, Health and Production. Today competitors are already involved in the development of sensor systems for applications in the emerging Internet of Things. But there is a significant gap between those forces and the capabilities to bring ideas into the high volume market fast enough. IoSense will close this gap by providing three modular flexible pilot lines being seamless integrated in the IoT value crating networks and ready to manufacture each kind of sensor system prototypes. IoSense will increase the manufacturing capacity of sensor/MEMS components in the involved pilot lines by factor of 10 while reducing manufacturing cost and time by 30%. IoSense is designed to enable focused development work on technological and application oriented tasks combining with market orientation. Design to Market Needs will be accomplished by customer involvement, embedding all required functionality besides sensors. Finally, the time for idea-to-market for new sensor systems is intended to be brought down to less than one year. As a result, semiconductor manufacturing will get a new boost in Europe enabling the industry with competitive solutions, securing employment and providing answers to the upcoming challenges in the IoT era.
Agency: Cordis | Branch: H2020 | Program: MSCA-ITN-ETN | Phase: MSCA-ITN-2016 | Award Amount: 3.89M | Year: 2017
Personalized health is a European priority and one of the strategic research areas for Horizon 2020. This project advances the state-of-the-art of personal health technologies for affective disorders, estimated to be the highest ranking cause of disease by 2020. It marks a significant shift from the current wearable technologies capturing emotional responses whose understanding usually requires physicians input, to low-cost self-help technologies for visualizing, exploring and regulating emotions. AFFECTIVA integrates the latest Human-Computer Interaction and Biomedical Engineering findings in designing and developing personal health systems for mental health, with the most influential outcomes and models of emotion regulation from Clinical Psychology. The overall aim is to support self-understanding and successful adoption of adaptive emotion regulation strategies in daily life. AFFECTIVA will contribute towards four significant outcomes: (1) wearable systems for capturing emotion regulation, (2) applications for understanding emotions and their regulatory processes, (3) interactive tools for training adaptive emotion regulation strategies, and (4) theoretical contributions to emotion regulation research in real life. AFFECTIVA builds on exceptional European and North American expertise from both academic and private sector to provide personalized health research with a timely and much needed momentum to address the pressing social challenge of emotional wellbeing and health.